Stock Details
ALC is Alcon Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 71.66$. Average daily volumn in 3 months 948.93k. Market cap 34.33B

Stock symbol : ALC. Exchange : NYSE. Currency : USD
Lastest price : 69.22$. Total volume : 429.61k. Market state PRE
Click reload if you want to check the lastest price on market!!!

Alcon Inc. (ALC)
Last Price

Previous Close68.65
Day Range68.38-69.68
Bid68.70 x 800
Ask69.52 x 1.4k
Average Volume948.93k
Market Cap34.33B
52 Week Range63.92-88.78
Trailing P/E75.24
Foward P/E28.72
Dividend (Yield %)0.30%
Ex-Dividend Date2022-05-03

Financial Details

According to Alcon Inc.'s financial reports the company's revenue in 2021 were 8.29B an increase( +33.33%) over the years 2020 revenue that were of 6.83B. In 2021 the company's total earnings were 376M while total earnings in 2020 were -531M(-170.81%).

Loading ...


Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion ... vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Market Cap:
Total Assets:
Total Cash:

News about "Alcon Inc."


Top 10 Stock Picks of Roberto Mignone’s Bridger Management

Source from : Insider Monkey - 1 days ago

In this article, we discuss the top 10 stock picks of Roberto Mignone’s Bridger Management. If you want to skip our detailed analysis of Mignone’s history, investment philosophy, and hedge fund ...See details»

Here's Why Investors Should Retain Alcon (ALC) Stock For Now

Source from : Yahoo Finance - 13 days ago

Alcon Inc. ALC has been gaining from strength across the Surgical and Vision Care franchises. The company exited the first quarter of 2022 with better-than-expected results. Its strategies to ...See details»

Alcon Inc - Stock Ownership ALC

Source from : Morningstar%2c Inc. - 6 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»

Kala Announces Entry Into Definitive Agreement To Sell EYSUVIS® And INVELTYS® To Alcon Inc.

Source from : Middle East North Africa Financial Network - 1 month ago

today announced that it has entered into a definitive agreement to sell its commercial portfolio and related intellectual property assets to Alcon Inc. This includes EYSUVIS, the first and only U ...See details»

Alcon Prices EUR 500.0 Million Senior Notes Offering

Source from : Stockhouse - 1 month ago

Alcon Inc. (SIX/NYSE: ALC), today announced that it has commenced and priced a public offering of EUR 500 million aggregate principal amount of its 2.375% senior notes due 2028 (the ...See details»

Alcon: Revisiting The Investment Thesis

Source from : Seeking Alpha - 27 days ago

Alcon Inc. (NYSE:ALC) recently published Q1 FY22 results which came in better than expected. The company maintains a double-digit revenue growth rate and is well on track to achieve its full-year ...See details»

Optometry Professional Market May See a Big Move : Alcon, Haag-Streit, Nidek

Source from : Digital Journal - 9 days ago

Key Players in This Report Include: Bausch & Lomb Inc (Canada), Carl Zeiss Meditec AG (Germany), Alcon Inc (Switzerland), Johnson & Johnson Vision Care Inc. (United States), Essilor International ...See details»

PRO Awards Gold: Best Cross-Channel Campaign 2016-Alcon’s Howard and the Amazing Eye Exam

Source from : Chief Marketer - 28 days ago

Alcon had been seeing stagnant sales of its over-the-counter eye-care products. Making matters worse, it was losing shelf space and volume at Walmart, which accounted for one-third of its business.See details»

New Suit

Source from : Law - 6 days ago

The suit targets Alcon Research LLC and GD Group USA Company, doing business as GD Medical Inc. Medmarc seeks a declaration that it has no duty to defend or indemnify GD in underlying claims ...See details»

Ophthalmic Lasers Market is estimated to increase from a valuation of US$ 884.3 Million in 2022

Source from : PharmiWeb - 3 days ago

Pages Report] Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market is no exception. Over the years, ophthalmic disorders such as ...See details»

Ophthalmic Drugs Market to Observe Exponential Growth By 2022 to 2030 | Alcon, Merck, Co

Source from : Digital Journal - 8 days ago

Moreover, the presence of central members like Pfizer, Inc., and Alcon in this area is supposed to additional improve the market development. For example, in February 2020, Alcon got an ...See details»

Alcon (ALC) Signs EYSUVIS-Buyout Deal With Kala Pharmaceuticals

Source from : Yahoo Finance - 19 days ago

Alcon Inc. ALC recently inked a deal to acquire EYSUVIS (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals, Inc. The acquisition adds to Alcon’s Systane family ...See details»

Patent office rejects IP Alliance’s pre grant opposition; grants patent to Alcon Research’s ophthalmic drug

Source from : Pharmabiz - 7 days ago

Patent office rejects IP Alliance’s pre grant opposition; grants patent to Alcon Research’s ophthalmic drug: Gireesh Babu, New Delhi Thursday, June 23, 2022, 08:00 Hrs [IST] I ...See details»

Eye Drops & Lubricants Market Brief Analysis on Leading Market Players

Source from : Medgadget - 26 days ago

Factors such as Increase in prevalence of eye-related diseases, high adoption of digital devices, and rise in geriatric populations have fuelled the growth of global market. Leading market players ...See details»